LONDON, September 10, 2018 /PRNewswire/ --
Swiss based pharmaceutical company Sintetica SA has another award to addto its already impressive collection, having been named 'Pharmaceutical Company of the Year - Europe' in the 2018 Brand of the Year Awards by Business Worldwide Magazine.
The 2018 Brand of the Year
Sintetica SA's CEO Augusto Mitidieri is leading the way in a new business model that encourages collaborative and horizontal working, combining state of the art technology with a human-centred approach. The company has come a long way since it was formed almost 100 years ago, going from a small business in Switzerland to a global company employing 300 people across 29 countries. Delivering injectable anaesthetics and analgesics to patients worldwide, the company has been the market leader in its field for many years and is now forging the way in the growing field of neuromodulation. The global division was only established in 2012, but growth is already exceeding 200% - a testament to the hard work and commitment of the CEO and his team.
Mitidieri says that the company's culture of respect has played an important role in its success. "What differentiates us from competitors is that all strategic choices are based on values of respect, a core value that permeates across every employee. It is about creating a pleasant environment in which employees can work and express themselves. When hiring new employees, we look for 'smart' people who share our thirst for diversity, our respect for traditions and our aim to be a leading global company."
This "people first" approach extends way beyond the staff team, positively affecting relationships with business partners and realising the best possible care solutions for patients. Mitidieri's innovative new organisation model, the 'Human Centred Organisation', is based on the idea of responsibility and meritocracy rather than hierarchy, with managers moving from a role of command to a coaching style.
This refreshing approach certainly appears to be working. The company has recently obtained the go-ahead to market a new drug application in the United States; an outstanding achievement as one of the few small-medium sized companies in the world to register a new product in the US. It is also developing a radical new innovation in the field of post-surgery pain relief that has the potential to change the way pain is managed throughout the world.
To find out more about the company's business model, developments and successes so far, visit http://www.sintetica.com/
Further details about the BWM Awards can be found at https://www.bwmonline.com/awards/
An article on the company can also be found on BWM website
About Business Worldwide Magazine Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world. Our quarterly magazine and online news portal enables an established audience of corporate dealmakers to track the latest news, stories and developments affecting the international markets, corporate finance, business strategy and changes in legislation. This readership includes of CEO/CFO - Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few. http://www.bwmonline.com
Contact David Jones Awards Department E: email@example.com
SOURCE Business Worldwide Magazine
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All